Amyloid-β Peptides Activate α 1 -Adrenergic Cardiovascular Receptors-Reference-Cited by-同舟云学术

Amyloid-β Peptides Activate α 1 -Adrenergic Cardiovascular Receptors

Published:2013-11 Issue:5 Volume:62 Page:966-972
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Haase Nadine¹,Herse Florian¹,Spallek Bastian¹,Haase Hannelore¹,Morano Ingo¹,Qadri Fatimunnisa¹,Szijártó István A.¹,Rohm Ilonka¹,Yilmaz Atilla¹,Warrington Junie P.¹,Ryan Michael J.¹,Gollasch Maik¹,Müller Dominik N.¹,Dechend Ralf¹,Wallukat Gerd¹

Affiliation:

1. From the Experimental and Clinical Research Center, a joint cooperation between the Max-Delbrueck Center for Molecular Medicine and the Charité Medical Faculty, Berlin, Germany (N.H., F.H., B.S., F.Q., I.A.S., M.G., D.N.M., R.D., G.W.); Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany (H.H., I.M.); Department of Cardiology and Nephrology, HELIOS-Klinikum Berlin, Berlin, Germany (R.D.); Department of Cardiology, Jena University Hospital, Jena, Germany (I.R., A.Y.); and Department of...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference31 articles.

1. The Many Faces of Amyloid β in Alzheimers Disease

2. Alzheimer's Disease

3. Proteolytic processing of Alzheimer’s β-amyloid precursor protein

4. Amyloid Precursor Protein Trafficking, Processing, and Function

5. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase Inhibitors;Cells;2023-12-14

2. Amyloid-β: A potential mediator of aging-related vascular pathologies;Vascular Pharmacology;2023-10

3. A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease;Expert Opinion on Pharmacotherapy;2023-03-28

4. Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers;Alzheimer's & Dementia;2022-11-19

5. Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance;PLOS ONE;2022-10-06